- Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide
-
Ro J, Cheng FT, Sriuranpong V, Villalon A, Smruti BK, Tsang J, Yap YS, Asian Working Group for Eribulin Clinical Guide
- KMID: 2176316
- J Breast Cancer.
- 2016 Mar;19(1):8-17.
- doi: 10.4048/jbc.2016.19.1.8
Eribulin, an antimicrotubule chemotherapeutic agent, is approved for the treatment of pretreated metastatic breast cancer (mBC) based on the positive outcomes of phase II and phase III clinical trials, which... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
-
Cho BC, Kim DW, Batra U, Park K, Kim SW, Yang CT, Voon PJ, Sriuranpong V, Babu KG, Amin K, Wang Y, Sen P, Slimane K, Geater S
- KMID: 2537994
- Cancer Res Treat.
- 2023 Jan;55(1):83-93.
- doi: 10.4143/crt.2021.1571
Purpose Previous report from the ASCEND-8 trial showed consistent efficacy with less gastrointestinal (GI) toxicity in patients with anaplastic lymphoma kinase-rearranged (ALK+) advanced/metastatic non–small cell lung cancer (NSCLC) treated with... -
- CITED
-
- Close
- SHARE
-
- Close
